Lv729
3920 积分 2024-10-23 加入
Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease
24天前
已完结
Estimating the financial cost of chronic kidney disease to the NHS in England
24天前
已关闭
Cardiovascular disease in chronic kidney disease
24天前
已完结
Epidemiology of chronic kidney disease: an update 2022
24天前
已完结
Chronic Kidney Disease and Mortality Risk
24天前
已关闭
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
24天前
已完结
Chronic kidney disease and the global public health agenda: an international consensus
24天前
已完结
Cardiometabolic risk phenotypes and chronic kidney disease incidence in older adults: a nationwide longitudinal cohort study
28天前
已完结
Prevalence of Chronic Kidney Disease in China
28天前
已完结
Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
28天前
已完结
皖公网安备34019202002308
